# Cambrex Profarmaco Milano Srl - Inspection Records

Source: https://www.keypedia.com/companies/cambrex-profarmaco-milano-srl/5855fd12-020f-4975-9bc0-f5358c581aef

> Inspection records and compliance data for Cambrex Profarmaco Milano Srl in Paullo, None. Access full analysis and detailed observations.

---

## Details

- Name: Cambrex Profarmaco Milano Srl
- FEI Number: 3003723076
- City: Paullo
- State: None
- Country Name: Italy
- Address Line 1: Via Eugenio Curiel 34
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING

## Related Documents

- [EIR - Cambrex Profarmaco Milano Srl - 2022-11-11](https://www.keypedia.com/records/eir/cambrex-profarmaco-milano-srl/921bbfb4-4c94-4340-bea6-ba05ace69fab) — source: FDA, date: November 11, 2022
- [EIR - Cambrex Profarmaco Milano Srl - 2022-11-11](https://www.keypedia.com/records/eir/cambrex-profarmaco-milano-srl/6dcb380c-1dff-43ee-aca6-6b78c06bc4f8) — source: FDA, date: November 11, 2022
- [FDA Inspection 1193220 - Cambrex Profarmaco Milano Srl - 2022-11-11](https://www.keypedia.com/records/fda_inspections/cambrex-profarmaco-milano-srl/d517f310-c80c-4a43-a918-722116697891) — classification: No Action Indicated (NAI), source: FDA, date: November 11, 2022
- [FDA Inspection 1167505 - Cambrex Profarmaco Milano Srl - 2021-10-01](https://www.keypedia.com/records/fda_inspections/cambrex-profarmaco-milano-srl/3114044e-b44b-42ac-a9be-195c5a8ed9fd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 1, 2021
- [FDA Inspection 1091698 - Cambrex Profarmaco Milano Srl - 2019-05-07](https://www.keypedia.com/records/fda_inspections/cambrex-profarmaco-milano-srl/bd16f1a7-cc5f-4eeb-b6ad-9272d5a933dd) — classification: No Action Indicated (NAI), source: FDA, date: May 7, 2019
- [FDA Inspection 1021644 - Cambrex Profarmaco Milano Srl - 2017-05-19](https://www.keypedia.com/records/fda_inspections/cambrex-profarmaco-milano-srl/66ac1960-e277-4a92-bdb1-667be3edb250) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 19, 2017
- [483 - Cambrex Profarmaco Milano Srl - 2017-05-15](https://www.keypedia.com/records/483/cambrex-profarmaco-milano-srl/98492161-19f3-4b0d-b291-07625e7fcc66) — source: FDA, date: May 15, 2017
- [FDA Inspection 973972 - Cambrex Profarmaco Milano Srl - 2015-11-06](https://www.keypedia.com/records/fda_inspections/cambrex-profarmaco-milano-srl/761e9440-2faa-4cf8-8971-9bcfbc86cdb6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 6, 2015
- [FDA Inspection 861141 - Cambrex Profarmaco Milano Srl - 2013-12-06](https://www.keypedia.com/records/fda_inspections/cambrex-profarmaco-milano-srl/e57c2a65-8bb6-48d6-a40b-a01c7fd5caef) — classification: No Action Indicated (NAI), source: FDA, date: December 6, 2013
- [FDA Inspection 723863 - Cambrex Profarmaco Milano Srl - 2011-03-25](https://www.keypedia.com/records/fda_inspections/cambrex-profarmaco-milano-srl/1a2c2398-3bc2-4093-b38f-d3af3fb60532) — classification: No Action Indicated (NAI), source: FDA, date: March 25, 2011
- [FDA Inspection 575657 - Cambrex Profarmaco Milano Srl - 2009-03-31](https://www.keypedia.com/records/fda_inspections/cambrex-profarmaco-milano-srl/c6818a57-db50-4737-ad33-981a70bf9c2e) — classification: Official Action Indicated (OAI), source: FDA, date: March 31, 2009

## Related Companies

- [Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC](https://www.keypedia.com/companies/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/0de9118f-18ec-45b8-b757-44f97c13c29c)
- [Sumitomo Chemical Co., Ltd.](https://www.keypedia.com/companies/sumitomo-chemical-co-ltd/3ce10d51-6999-467f-ac0e-cb6696a98aa5)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/cefc1473-6852-4af7-b996-0730dc0834bb)
- [Divi's Laboratories Ltd. (Unit II)](https://www.keypedia.com/companies/divis-laboratories-ltd-unit-ii/b2498cb9-d277-498a-b32b-037e04f6feaf)
- [Matrix Pharmacorp Private Limited](https://www.keypedia.com/companies/matrix-pharmacorp-private-limited/3cbdd9ae-291e-406d-9e2c-5479410bf998)
- [Cipla Ltd.](https://www.keypedia.com/companies/cipla-ltd/d90a952b-3052-4e33-9969-5db3f2bbae82)
- [Pfizer Asia Manufacturing Pte Ltd.](https://www.keypedia.com/companies/pfizer-asia-manufacturing-pte-ltd/77c4ecfd-af67-404b-8091-9c254525198b)
- [Teva API India Private Ltd.](https://www.keypedia.com/companies/teva-api-india-private-ltd/aeeb5a05-7558-44f6-a08a-bb2f3d1aa3de)
- [Eisai Co., Ltd. Kashima Plant](https://www.keypedia.com/companies/eisai-co-ltd-kashima-plant/70a3ccaf-c591-4ebf-952a-a2ee6a62e53c)
- [University of Missouri - Columbia Research Reactor Center](https://www.keypedia.com/companies/university-of-missouri-columbia-research-reactor-center/8b52f6ac-83c0-4557-834e-e421d6114e0b)

## Related Officers

- [Temar Q. Williams](https://www.keypedia.com/people/temar-q-williams/624784fb-dd87-482b-9e8c-a6d79736b132)
- [Margaret M. Annes](https://www.keypedia.com/people/margaret-m-annes/e528fbbe-2a4c-4697-9256-b7f2d0bcd279)
- [Investigator](https://www.keypedia.com/people/douglas-c-kovacs/2fd80a0c-1314-4eb0-a14b-c98e65bade81)
- [investigator](https://www.keypedia.com/people/monika-borkowska/4dedee7d-7b93-4f1b-be3b-17ab41e5c0ff)